查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1939254

2026年人工智慧（AI）体外诊断（IVD）全球市场报告

Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，人工智慧（AI）在体外诊断医疗设备（IVD）市场的规模迅速扩张，预计将从2025年的30.4亿美元成长到2026年的36亿美元，复合年增长率（CAGR）为18.4%。过去几年的成长归因于以下因素：对精准诊断的需求不断增长、检查室基础设施的扩建、慢性病患病率的上升、数位诊断工具的引入以及生物标誌物研究的进展。

预计未来几年，体外诊断医疗设备（IVD）市场中的人工智慧（AI）领域将快速成长，到2030年市场规模将达到70.1亿美元，复合年增长率（CAGR）为18.1%。预测期内的成长要素包括：云端诊断平台的扩张、人工智慧与基因组学的融合、照护现场AI诊断技术的开发、个人化医疗投资的增加以及对快速且经济高效的检测日益增长的需求。预测期内的关键趋势包括：人工智慧驱动的检查室自动化、疾病预测性诊断、数据驱动的检测结果解读、云端诊断平台以及个人化患者画像。

个人化医疗需求的不断增长预计将推动人工智慧 (AI) 在体外诊断 (IVD) 市场的扩张。个人化医疗根据个人的基因谱、生活方式和环境，客製化预防、诊断和治疗方案。基因组数据和定序技术的进步极大地促进了个人化医疗的普及，使治疗更加精准、有效和有针对性。人工智慧在体外诊断领域发挥关键作用，它能够分析复杂的诊断数据，识别患者特有的疾病模式，并帮助医疗服务提供者做出及时且准确的治疗决策。例如，根据个人化医疗联盟 (PMC) 的报告，截至 2024 年 2 月，美国食品药物管理局 (FDA)核准16 种针对罕见疾病的新型个人化疗法，较 2022 年的 6 种显着增加。这些疗法包括 7 种癌症疗法和 3 种其他疾病疗法。对个人化医疗日益增长的需求正在推动人工智慧在体外诊断领域的发展。

体外诊断（IVD）领域人工智慧（AI）的市场领导者正致力于开发先进的解决方案，旨在提高诊断准确性、简化工作流程并支援个人化医疗。具体而言，他们正在开发通过CE-IVDR认证的透明AI平台。这些AI系统符合欧盟监管标准，并提供清晰且审核的决策流程。 2025年5月，总部位于英国的诊断检测公司Diagnostics.ai发布了PCR.AI，这是一款旨在加快PCR诊断速度并提高其准确性的先进解决方案。该平台能够自动解读即时PCR结果，准确率超过99.9%，并透过清晰展示每个结果的推导过程来提高透明度。此功能确保了符合监管要求，并增强了临床可靠性。此外，它还显着提高了检查室效率，减少了错误，并支持分子诊断领域无缝衔接的监管合规性。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球人工智慧（AI）赋能的体外诊断（IVD）市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 生物技术、基因组学和精准医学
    • 物联网、智慧基础设施和互联生态系统
    • 工业4.0和智慧製造
  • 主要趋势
    • 利用人工智慧实现检查室自动化
    • 预测性疾病诊断
    • 数据驱动的测试结果解读
    • 基于云端的诊断平台
    • 个人化病患檔案

第五章 终端用户产业市场分析

  • 医院和诊所
  • 诊断检查室
  • 研究所
  • 製药公司
  • 医疗设备製造商

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球人工智慧（AI）赋能的体外诊断（IVD）市场：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球人工智慧（AI）体外诊断（IVD）市场规模、对比及成长率分析
  • 全球人工智慧（AI）赋能的体外诊断（IVD）市场表现：规模与成长，2020-2025年
  • 全球人工智慧（AI）赋能的体外诊断（IVD）市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按组件
  • 软体、硬体和服务
  • 透过技术
  • 机器学习、自然语言处理、电脑视觉、机器人流程自动化、深度学习
  • 按部署模式
  • 云端部署、本地部署、混合部署
  • 透过使用
  • 诊断影像、临床检测、病理学、基因组学、个人化医疗
  • 最终用户
  • 医院和诊所、诊断检查室、研究机构、製药公司、医疗设备製造商
  • 按类型细分：软体
  • 诊断演算法、数据分析平台、决策支援系统
  • 按类型细分：硬体
  • 检查设备、诊断影像设备、照护现场设备
  • 按类型细分：服务
  • 咨询和实施支援、维护和支援、培训和教育

第十章 区域与国家分析

  • 全球基于人工智慧 (AI) 的体外诊断 (IVD) 市场：区域表现及预测，2020-2025 年、2025-2030 年预测、2035 年预测
  • 全球基于人工智慧 (AI) 的体外诊断 (IVD) 市场：国家/地区、绩效及预测，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 人工智慧（AI）体外诊断（IVD）市场：竞争格局和市场份额，2024年
  • 人工智慧（AI）赋能的体外诊断（IVD）市场：公司估值矩阵
  • 人工智慧（AI）赋能的体外诊断（IVD）市场：公司概况
    • Roche Diagnostics GmbH
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers AG

第37章：其他领先和创新企业

  • Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN NV, Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年人工智慧（AI）体外诊断（IVD）市场：提供新机会的国家
  • 2030年人工智慧（AI）体外诊断（IVD）市场：提供新机会的细分市场
  • 2030年人工智慧（AI）体外诊断（IVD）市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MAIAI10_G26Q1

Artificial intelligence (AI) in in vitro diagnostics (IVD) refers to the application of advanced algorithms to analyze medical data obtained from laboratory tests on samples such as blood, tissue, or urine. It enables faster, more accurate, and data-driven interpretation of test results, supporting early disease detection, personalized treatment decisions, and enhanced diagnostic efficiency.

The primary components of AI in in vitro diagnostics include software, hardware, and services. Software consists of programs and data that instruct a computer to perform specific tasks. It leverages technologies such as machine learning, natural language processing, computer vision, robotic process automation, and deep learning, and can be deployed through cloud-based, on-premise, or hybrid methods. Applications include diagnostic imaging, laboratory testing, pathology, genomics, and personalized medicine. Primary end users include hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical companies, and medical device manufacturers.

Tariffs are impacting the ai in vitro diagnostics market by increasing costs of importing laboratory instruments, diagnostic software, and biomarker testing kits, particularly in asia-pacific and european regions. Hardware-heavy segments like laboratory instruments and imaging devices are most impacted, causing delays and higher operational costs for diagnostic laboratories. On the positive side, tariffs are driving local production and innovation, leading to more cost-efficient ai-based diagnostic solutions and regional manufacturing capabilities.

The artificial intelligence (AI) in in vitro diagnostics (ivd) market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in in vitro diagnostics (ivd) market statistics, including artificial intelligence (AI) in in vitro diagnostics (ivd) industry global market size, regional shares, competitors with a artificial intelligence (AI) in in vitro diagnostics (ivd) market share, detailed artificial intelligence (AI) in in vitro diagnostics (ivd) market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in in vitro diagnostics (ivd) industry. This artificial intelligence (AI) in in vitro diagnostics (ivd) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (ai) in in vitro diagnostics (ivd) market size has grown rapidly in recent years. It will grow from $3.04 billion in 2025 to $3.6 billion in 2026 at a compound annual growth rate (CAGR) of 18.4%. The growth in the historic period can be attributed to rising demand for accurate diagnostics, growth of laboratory infrastructure, increasing prevalence of chronic diseases, adoption of digital diagnostic tools, advancements in biomarker research.

The artificial intelligence (ai) in in vitro diagnostics (ivd) market size is expected to see rapid growth in the next few years. It will grow to $7.01 billion in 2030 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to expansion of cloud-based diagnostic platforms, integration of ai with genomics, development of point-of-care ai diagnostics, growing investments in personalized medicine, increasing demand for rapid and cost-effective testing. Major trends in the forecast period include AI-enabled laboratory automation, predictive disease diagnostics, data-driven test interpretation, cloud-based diagnostic platforms, personalized patient profiling.

The growing demand for personalized medicine is expected to drive the expansion of the artificial intelligence (AI) in in vitro diagnostics (IVD) market. Personalized medicine involves tailoring prevention, diagnosis, and treatment based on an individual's genetic profile, lifestyle, and environment. The increasing adoption of personalized medicine is largely fueled by advancements in genomic data and sequencing technologies, which allow for more precise, effective, and targeted treatments. AI in IVD plays a vital role by analyzing complex diagnostic data to identify disease patterns specific to each patient, helping healthcare providers make timely and accurate treatment decisions. For example, the Personalized Medicine Coalition reported that in February 2024, the FDA approved 16 new personalized treatments for rare diseases in 2023, a significant increase from six in 2022. This includes seven cancer drugs and three treatments for other conditions. The rising demand for personalized medicine is thus driving the growth of AI in IVD.

Companies in the AI in IVD market are focused on developing advanced solutions, such as CE-IVDR-certified transparent AI platforms, to improve diagnostic accuracy, streamline workflows, and support personalized patient care. A CE-IVDR-certified transparent AI platform is an AI system that meets EU regulatory standards, providing clear, auditable decision-making. In May 2025, Diagnostics.ai, a UK-based diagnostic testing company, launched PCR.AI, an advanced solution designed to speed up and improve PCR diagnostics. This platform automates real-time PCR result interpretation with over 99.9% accuracy, offering transparency by clearly displaying how each result is derived. This feature ensures regulatory compliance and enhances clinical trust. It also significantly boosts laboratory efficiency, reduces errors, and supports seamless regulatory adherence for molecular diagnostics.

In April 2025, bioMerieux SA, a France-based company specializing in AI for IVD, partnered with Mila, a Canadian AI research institute, to advance research and innovation in AI-driven diagnostics and antibiotic resistance detection. The collaboration aims to create cutting-edge AI solutions that enhance the accuracy and efficiency of IVD tools, with a particular focus on improving the detection of antibiotic resistance. Mila is renowned for its pioneering work in machine learning and AI research.

Major companies operating in the artificial intelligence (ai) in in vitro diagnostics (ivd) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, Aiforia Technologies Oyj

North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial intelligence (AI) in in vitro diagnostics (IVD) market includes revenues earned by entities by providing services such as predictive analytics services, remote diagnostic and telepathology services, workflow automation, optimization services, data annotation, and clinical decision support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in in vitro diagnostics (IVD) market also includes sales of automated laboratory instruments, artificial intelligence-enabled digital pathology scanners, and liquid biopsy diagnostic kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence (ai) in in vitro diagnostics (ivd) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) in in vitro diagnostics (ivd) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) in in vitro diagnostics (ivd) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Software; Hardware; Services
  • 2) By Technology: Machine Learning; Natural Language Processing; Computer Vision; Robotics Process Automation; Deep Learning
  • 3) By Deployment Model: Cloud-Based; On-Premise; Hybrid
  • 4) By Application: Diagnostic Imaging; Laboratory Testing; Pathology; Genomics; Personalized Medicine
  • 5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Pharmaceutical Companies; Medical Device Manufacturers
  • Subsegments:
  • 1) By Software: Diagnostic Algorithms; Data Analytics Platforms; Decision Support Systems
  • 2) By Hardware: Laboratory Instruments; Imaging Devices; Point-Of-Care Devices
  • 3) By Services: Consulting And Implementation; Maintenance And Support; Training And Education
  • Companies Mentioned: Roche Diagnostics GmbH; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Illumina Inc.; Hologic Inc.; Sysmex Corporation; QIAGEN N.V.; Tempus Labs Inc.; BillionToOne Inc.; PathAI Inc.; Proscia Inc.; Indica Labs Inc.; Visiopharm A/S; aetherAI Co. Ltd.; Ibex Medical Analytics Ltd.; Mindpeak GmbH; OncoHost Ltd.; Qritive; Aiforia Technologies Oyj
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Biotechnology, Genomics & Precision Medicine
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Ai-Enabled Laboratory Automation
    • 4.2.2 Predictive Disease Diagnostics
    • 4.2.3 Data-Driven Test Interpretation
    • 4.2.4 Cloud-Based Diagnostic Platforms
    • 4.2.5 Personalized Patient Profiling

5. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Research Institutes
  • 5.4 Pharmaceutical Companies
  • 5.5 Medical Device Manufacturers

6. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Segmentation

  • 9.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software, Hardware, Services
  • 9.2. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning
  • 9.3. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cloud-Based, On-Premise, Hybrid
  • 9.4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine
  • 9.5. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers
  • 9.6. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems
  • 9.7. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Laboratory Instruments, Imaging Devices, Point-Of-Care Devices
  • 9.8. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consulting And Implementation, Maintenance And Support, Training And Education

10. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Regional And Country Analysis

  • 10.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 11.1. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 12.1. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 13.1. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 14.1. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 15.1. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 16.1. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 17.1. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 18.1. Taiwan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 19.1. South East Asia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 20.1. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 21.1. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 22.1. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 23.1. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 24.1. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 25.1. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 26.1. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 27.1. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 28.1. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 29.1. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 30.1. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 31.1. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 32.1. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 33.1. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 34.1. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Regulatory and Investment Landscape

36. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Landscape And Company Profiles

  • 36.1. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Company Profiles
    • 36.3.1. Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Other Major And Innovative Companies

  • Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive

38. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

40. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market High Potential Countries, Segments and Strategies

  • 40.1 Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer